BZAM partners C Labs for UK medical cannabis

  • BZAM Ltd. & 4C Labs Conclude Strategic Distribution Agreement for the UK Market. BZAM Ltd., a leading European cannabis cultivator and producer, has announced a strategic distribution agreement with 4C Labs, a UK-based medical cannabis company. The agreement will see 4C Labs distribute BZAM’s medical cannabis products to patients in the UK.Opens in a new windowbusinessofcannabis.comBZAM Ltd.
  • Unveiling the Secrets of High-Yield Cannabis Cultivation: Premier Tech Dives into Optimal Growing Mediums. Premier Tech, a global leader in horticultural technologies, has released a new white paper that delves into the secrets of high-yield cannabis cultivation. The white paper explores the importance of using the right growing medium to optimize cannabis growth and yield.Opens in a new windowbulkinside.comPremier Tech
  • Rokshaw Announces Launch of Four20 Medical Cannabis Products in the UK. Rokshaw Developments Ltd., a UK-based medical cannabis company, has announced the launch of its Four20 range of medical cannabis products. The Four20 range includes a variety of flower and oil products that are available to patients with a prescription.Opens in a new windowrokshaw.co.ukRokshaw Developments Ltd.
  • Ukraine’s Medical Cannabis Legalisation Delayed by Opponents. The Ukrainian government has delayed the legalization of medical cannabis due to opposition from some lawmakers. The delay is a setback for patients who are hoping to use cannabis to treat a variety of medical conditions.Opens in a new windowwww.globalr2p.orgUkraine
  • Cantourage Reports ‘Singificant Revenue Growth’ for 2023, Europe’s Last Cannabis ETF Closes, & SEED Innovations Publishes Interim Results. Cantourage, a European cannabis company, has reported “significant revenue growth” for 2023. Meanwhile, Europe’s last cannabis ETF has closed, and SEED Innovations has published its interim results.Opens in a new windowmediorbis.deCantourage

I hope this information is helpful. Please let me know if you have any other questions.

Sources

info

  1. businessofcannabis.com/

BZAM Ltd. & 4C Labs Conclude Strategic Distribution Agreement for the UK Market. BZAM Ltd., a leading European cannabis cultivator and producerhas announced a strategic distribution agreement with 4C Labs, a UK-based medical cannabis company. The agreement will see 4C Labs distribute BZAM’s medical cannabis products to patients in the UK.

volume_up

That’s great news for both companies! This agreement will help to expand BZAM’s reach into the UK market and give 4C Labs access to a high-quality supply of medical cannabis products. I’m sure that this partnership will be beneficial for both companies and for patients in the UK.

Sure, here are the sources for the information I provided:

Categories: Uncategorized